The United States has imposed sanctions on a network of entities and individuals in India and China accused of supplying precursor chemicals and equipment to the Sinaloa cartel for the production of fentanyl and other opioids. The action, announced by the US Treasury Department, targets six entities and four individuals, including Indian companies and their owners.
Sanctions Target Key Players
The Treasury's Office of Foreign Assets Control (OFAC) designated two India-based companies—Avantor Performance Materials India Ltd. and S. K. Enterprises—along with their owners, for allegedly procuring and shipping precursor chemicals and laboratory equipment to Mexico for the cartel. The sanctions freeze any US assets of the designated parties and prohibit American citizens from doing business with them.
Role of Indian Entities
According to the Treasury, Avantor Performance Materials India Ltd. supplied chemicals used in the synthesis of fentanyl, while S. K. Enterprises provided laboratory glassware and equipment. Both companies reportedly shipped these items to Mexico, where the Sinaloa cartel operates clandestine labs to produce counterfeit pills and other drugs. The sanctions also target the owners of these firms, who are accused of facilitating the transactions.
Broader Implications for India
The sanctions highlight the growing concern over India's role in the global opioid supply chain. Indian pharmaceutical companies are major producers of generic drugs and chemical precursors, which can be diverted for illicit use. The US has been pressuring India to tighten controls on the export of precursor chemicals, but enforcement remains challenging. This action is part of a wider US effort to combat the fentanyl crisis, which has caused tens of thousands of overdose deaths annually.
International Coordination
The sanctions also target individuals and entities in China, which is another major source of precursor chemicals. The US is working with international partners to disrupt the supply chain, but critics argue that more needs to be done to address the demand side of the crisis. The Treasury stated that the sanctions are intended to "disrupt the financial infrastructure" supporting the cartel's operations.
Impact on Indian Businesses
Indian companies named in the sanctions could face reputational damage and loss of business with US partners. The Indian government has not yet commented on the sanctions, but it is expected to review its export controls to prevent future violations. Industry experts warn that the sanctions could have a chilling effect on legitimate trade if not handled carefully.
The US action underscores the importance of supply chain integrity in the pharmaceutical sector. Companies involved in the production and export of chemicals must ensure robust compliance measures to avoid being used as conduits for illegal activities.
